XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Fair Value of MRI EICP Options and Valuation Assumptions The fair value of the MRI EICP options was estimated using the Black-Scholes option pricing model with the following weighted-average assumptions (no dividends were expected):
    
Grant Date
 
Risk-free interest rate
     0.5
Expected volatility
     32.0
Expected option life (in years)
     5.5  
Grant-date fair value
   $ 3.44  
Summary of Outstanding Activity of Options,Restricted Stock and Restricted Stock Units under MRI EICP
The following table summarizes the restricted shares, restricted stock units and options outstanding under the MRI EICP as of December 31, 2021:
 
    
Restricted Shares
    
Restricted Stock Units
    
Options
 
    
Number of
Shares
   
Weighted
Average
Grant Date
Fair Value
    
Number of
Shares
   
Weighted
Average
Grant Date
Fair Value
    
Number of
Shares
    
Weighted
Average
Exercise
Price
 
End of period—December 31, 2020
  
 
—  
 
 
$
—  
    
 
—  
 
 
$
—  
    
 
—  
 
  
$
—  
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Beginning of period—January 1, 2021
     —       $ —          —       $ —          —        $ —    
Granted
     3,869,827       10.40        29,304       11.38        950,214        11.38  
Vested
     (950,214     11.38        —         —          —          —    
Forfeited
     —         —          (1,320     11.38        —          —    
Exercised
     —         —          —         —          —          —    
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
End of period—December 31, 2021
  
 
2,919,613
 
 
$
10.09
 
  
 
27,984
 
 
$
11.38
 
  
 
950,214
 
  
$
11.38
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Summary of Outstanding Activity of Options and Restricted Stock under SAR Plan
The following table summarizes the options and restricted stock under the SAR Plan as of December 31, 2020:
 
    
Options
    
Restricted Stock
 
    
Number of
Shares
    
Weighted
Average
Exercise
Price
    
Number of
Shares
    
Weighted
Average
Grant Date
Fair Value
 
End of period—December 31, 2019
  
 
1,872,534
 
  
$
1.18
 
  
 
1,939,200
 
  
$
0.95
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Beginning of period—January 1, 2020
     1,872,534      $ 1.18        1,939,200      $ 0.95  
Granted
     924,779        0.90        —          —    
Forfeited
     (166,666      0.62        —          —    
Exercised
     (50,000      0.44        —          —    
    
 
 
    
 
 
    
 
 
    
 
 
 
End of period—December 31, 2020
  
 
2,580,647
 
  
$
1.13
 
  
 
1,939,200
 
  
$
0.95
 
Vested and exercisable—December 31, 2020
  
 
50,000
 
  
$
0.56
 
  
 
1,939,200
 
  
$
0.95